Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahisa Shindo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Case Reports in Dermatology|February 12, 2014
Adverse Skin Reactions due to Ribavirin in Hepatitis C Combination Therapy with Pegylated Interferon-α2aMasahisa Shindo, Isamu Terai
Recent Patents on Inflammation & Allergy Drug Discovery|August 3, 2010
Regulatory T cells and skin tumorsMasahisa Shindo, Yuichi Yoshida
Biochemical and Biophysical Research Communications|March 12, 2004
The ectodermal dysplasia receptor represses the Lef-1/beta-catenin-dependent transcription independent of NF-kappaB activationMasahisa Shindo, Preet M Chaudhary
Pharmacology|February 25, 2011
Olopatadine hydrochloride inhibits capsaicin-induced flare response in humansMasahisa Shindo, Yuichi Yoshida, Osamu Yamamoto
Current Treatment Options in Oncology|March 29, 2019
Symptoms of and Palliative Treatment for Unresectable Skin CancerHiroyuki Goto, Yoshio Kiyohara, Masahisa Shindo, et al.
Yonago Acta Medica|September 14, 2013
Skin metastasis of hypopharyngeal carcinoma to the nasal tipMasahisa Shindo, Yuichi Yoshida, Kyoko Tominaga, et al.
The Journal of Dermatology|September 15, 2011
Syringocystadenoma papilliferum on the male nippleMasahisa Shindo, Nanako Yamada, Yuichi Yoshida, et al.
The Journal of Biological Chemistry|September 25, 2002
Role of TRAF3 and -6 in the activation of the NF-kappa B and JNK pathways by X-linked ectodermal dysplasia receptorSuwan K Sinha, Sunny Zachariah, Herson I Quiñones, et al.
The Journal of Dermatology|July 2, 2021
Clinical effectiveness of efinaconazole 10% solution for treatment of onychomycosis with longitudinal spikesShinichi Watanabe, Ken Iozumi, Masatoshi Abe, et al.
The Journal of Dermatology|June 18, 2019
Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm studyKen Iozumi, Masatoshi Abe, Yoshiko Ito, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Case Reports in Dermatology|February 12, 2014
Adverse Skin Reactions due to Ribavirin in Hepatitis C Combination Therapy with Pegylated Interferon-α2aMasahisa Shindo, Isamu Terai
Recent Patents on Inflammation & Allergy Drug Discovery|August 3, 2010
Regulatory T cells and skin tumorsMasahisa Shindo, Yuichi Yoshida
Biochemical and Biophysical Research Communications|March 12, 2004
The ectodermal dysplasia receptor represses the Lef-1/beta-catenin-dependent transcription independent of NF-kappaB activationMasahisa Shindo, Preet M Chaudhary
Pharmacology|February 25, 2011
Olopatadine hydrochloride inhibits capsaicin-induced flare response in humansMasahisa Shindo, Yuichi Yoshida, Osamu Yamamoto
Current Treatment Options in Oncology|March 29, 2019
Symptoms of and Palliative Treatment for Unresectable Skin CancerHiroyuki Goto, Yoshio Kiyohara, Masahisa Shindo, et al.
Yonago Acta Medica|September 14, 2013
Skin metastasis of hypopharyngeal carcinoma to the nasal tipMasahisa Shindo, Yuichi Yoshida, Kyoko Tominaga, et al.
The Journal of Dermatology|September 15, 2011
Syringocystadenoma papilliferum on the male nippleMasahisa Shindo, Nanako Yamada, Yuichi Yoshida, et al.
The Journal of Biological Chemistry|September 25, 2002
Role of TRAF3 and -6 in the activation of the NF-kappa B and JNK pathways by X-linked ectodermal dysplasia receptorSuwan K Sinha, Sunny Zachariah, Herson I Quiñones, et al.
The Journal of Dermatology|July 2, 2021
Clinical effectiveness of efinaconazole 10% solution for treatment of onychomycosis with longitudinal spikesShinichi Watanabe, Ken Iozumi, Masatoshi Abe, et al.
The Journal of Dermatology|June 18, 2019
Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm studyKen Iozumi, Masatoshi Abe, Yoshiko Ito, et al.
Pageof 1